2005P-0411
  

  
 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs 

  


  

  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC1763
  



  

  
Submitter : 
  

  
Dr. Andrew Pauli
  

  
Date & Time: 
  

  
02/13/2006 02:02:58
  



  

  
Organization : 
  

  
Dr. Andrew Pauli
  



  

  
Category : 
  

  
Health Professional
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 I strongly object to the complaint by Wyeth.  It is a shameless attempt to knock down competition after their drug has been shown to be unsafe. In any case, the FDA does not have authority over compounding pharmacies as state law governs this.

  The FDA should reject this complaint.  

Andrew Pauli, MD

Bellingham, WA